Purpura Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Non-Thrombocytopenic Purpura, Thrombocytopenic Purpura, Allergic Purpura); Cases (Acute, Chronic); Treatment (Corticosteroids, Intravenous Immunoglobulin, Other Drug Therapies) and Geography

Report Code: TIPRE00017823 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Purpura occurs when small blood vessels burst, causing blood to pool under the skin. This can create purple spots on the skin that range in size from small dots to large patches. Purpura spots are generally benign, but may indicate a more serious medical condition, such as a blood clotting disorder.

MARKET DYNAMICS

The purpura treatment market is driving due to the factors such as rising per capita income, and increasing number of people suffering with purpura and others. In addition, increasing advancements in pharmaceuticals and increasing number of emerging players are likely to offer growth opportunities for market.

MARKET SCOPE

The "Purpura Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Purpura treatment market with detailed market segmentation by type, cases, and treatment. The Purpura treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Purpura treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The purpura treatment market is segmented on the basis of type, cases, and treatment. On the basis of type, the market is segmented as Non-Thrombocytopenic Purpura, Thrombocytopenic Purpura and Allergic Purpura. On the basis of cases, the market is segmented into Acute and Chronic. On the basis of treatment, the market is segmented into corticosteroids, intravenous immunoglobulin, and other drug therapies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Purpura treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Purpura treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Purpura treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Purpura treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Purpura treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Purpura treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Purpura treatment in the global market. Below mentioned is the list of few companies engaged in the Purpura treatment market.

The report also includes the profiles of key players in Purpura treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Amgen Inc
  •  Bristol-Myers Squibb Company
  •  F. Hoffman-La Roche
  •  GlaxoSmithKline Plc.
  •  Grifols Biologicals Inc
  •  Hovione
  •  Novartis AG
  •  Pfizer Inc.
  •  Sanofi
  •  Celltrion Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Purpura Treatment Market - By Type
1.3.2 Purpura Treatment Market - By Cases
1.3.3 Purpura Treatment Market - By Treatment
1.3.4 Purpura Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PURPURA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PURPURA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PURPURA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PURPURA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PURPURA TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PURPURA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON-THROMBOCYTOPENIC PURPURA
7.3.1. Overview
7.3.2. Non-Thrombocytopenic Purpura Market Forecast and Analysis
7.4. THROMBOCYTOPENIC PURPURA
7.4.1. Overview
7.4.2. Thrombocytopenic Purpura Market Forecast and Analysis
7.5. ALLERGIC PURPURA
7.5.1. Overview
7.5.2. Allergic Purpura Market Forecast and Analysis
8. PURPURA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - CASES
8.1. OVERVIEW
8.2. CASES MARKET FORECASTS AND ANALYSIS
8.3. ACUTE
8.3.1. Overview
8.3.2. Acute Market Forecast and Analysis
8.4. CHRONIC
8.4.1. Overview
8.4.2. Chronic Market Forecast and Analysis
9. PURPURA TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. CORTICOSTEROIDS
9.3.1. Overview
9.3.2. Corticosteroids Market Forecast and Analysis
9.4. INTRAVENOUS IMMUNOGLOBULIN
9.4.1. Overview
9.4.2. Intravenous Immunoglobulin Market Forecast and Analysis
9.5. OTHER DRUG THERAPIES
9.5.1. Overview
9.5.2. Other Drug Therapies Market Forecast and Analysis
9.5.3. Romiplostim (Nplate) Market
9.5.3.1. Overview
9.5.3.2. Romiplostim (Nplate) Market Forecast and Analysis
9.5.4. Eltrombopag (Promacta) Market
9.5.4.1. Overview
9.5.4.2. Eltrombopag (Promacta) Market Forecast and Analysis
10. PURPURA TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Purpura Treatment Market Overview
10.1.2 North America Purpura Treatment Market Forecasts and Analysis
10.1.3 North America Purpura Treatment Market Forecasts and Analysis - By Type
10.1.4 North America Purpura Treatment Market Forecasts and Analysis - By Cases
10.1.5 North America Purpura Treatment Market Forecasts and Analysis - By Treatment
10.1.6 North America Purpura Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Purpura Treatment Market
10.1.6.1.1 United States Purpura Treatment Market by Type
10.1.6.1.2 United States Purpura Treatment Market by Cases
10.1.6.1.3 United States Purpura Treatment Market by Treatment
10.1.6.2 Canada Purpura Treatment Market
10.1.6.2.1 Canada Purpura Treatment Market by Type
10.1.6.2.2 Canada Purpura Treatment Market by Cases
10.1.6.2.3 Canada Purpura Treatment Market by Treatment
10.1.6.3 Mexico Purpura Treatment Market
10.1.6.3.1 Mexico Purpura Treatment Market by Type
10.1.6.3.2 Mexico Purpura Treatment Market by Cases
10.1.6.3.3 Mexico Purpura Treatment Market by Treatment
10.2. EUROPE
10.2.1 Europe Purpura Treatment Market Overview
10.2.2 Europe Purpura Treatment Market Forecasts and Analysis
10.2.3 Europe Purpura Treatment Market Forecasts and Analysis - By Type
10.2.4 Europe Purpura Treatment Market Forecasts and Analysis - By Cases
10.2.5 Europe Purpura Treatment Market Forecasts and Analysis - By Treatment
10.2.6 Europe Purpura Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Purpura Treatment Market
10.2.6.1.1 Germany Purpura Treatment Market by Type
10.2.6.1.2 Germany Purpura Treatment Market by Cases
10.2.6.1.3 Germany Purpura Treatment Market by Treatment
10.2.6.2 France Purpura Treatment Market
10.2.6.2.1 France Purpura Treatment Market by Type
10.2.6.2.2 France Purpura Treatment Market by Cases
10.2.6.2.3 France Purpura Treatment Market by Treatment
10.2.6.3 Italy Purpura Treatment Market
10.2.6.3.1 Italy Purpura Treatment Market by Type
10.2.6.3.2 Italy Purpura Treatment Market by Cases
10.2.6.3.3 Italy Purpura Treatment Market by Treatment
10.2.6.4 Spain Purpura Treatment Market
10.2.6.4.1 Spain Purpura Treatment Market by Type
10.2.6.4.2 Spain Purpura Treatment Market by Cases
10.2.6.4.3 Spain Purpura Treatment Market by Treatment
10.2.6.5 United Kingdom Purpura Treatment Market
10.2.6.5.1 United Kingdom Purpura Treatment Market by Type
10.2.6.5.2 United Kingdom Purpura Treatment Market by Cases
10.2.6.5.3 United Kingdom Purpura Treatment Market by Treatment
10.2.6.6 Rest of Europe Purpura Treatment Market
10.2.6.6.1 Rest of Europe Purpura Treatment Market by Type
10.2.6.6.2 Rest of Europe Purpura Treatment Market by Cases
10.2.6.6.3 Rest of Europe Purpura Treatment Market by Treatment
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Purpura Treatment Market Overview
10.3.2 Asia-Pacific Purpura Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Purpura Treatment Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Purpura Treatment Market Forecasts and Analysis - By Cases
10.3.5 Asia-Pacific Purpura Treatment Market Forecasts and Analysis - By Treatment
10.3.6 Asia-Pacific Purpura Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Purpura Treatment Market
10.3.6.1.1 Australia Purpura Treatment Market by Type
10.3.6.1.2 Australia Purpura Treatment Market by Cases
10.3.6.1.3 Australia Purpura Treatment Market by Treatment
10.3.6.2 China Purpura Treatment Market
10.3.6.2.1 China Purpura Treatment Market by Type
10.3.6.2.2 China Purpura Treatment Market by Cases
10.3.6.2.3 China Purpura Treatment Market by Treatment
10.3.6.3 India Purpura Treatment Market
10.3.6.3.1 India Purpura Treatment Market by Type
10.3.6.3.2 India Purpura Treatment Market by Cases
10.3.6.3.3 India Purpura Treatment Market by Treatment
10.3.6.4 Japan Purpura Treatment Market
10.3.6.4.1 Japan Purpura Treatment Market by Type
10.3.6.4.2 Japan Purpura Treatment Market by Cases
10.3.6.4.3 Japan Purpura Treatment Market by Treatment
10.3.6.5 South Korea Purpura Treatment Market
10.3.6.5.1 South Korea Purpura Treatment Market by Type
10.3.6.5.2 South Korea Purpura Treatment Market by Cases
10.3.6.5.3 South Korea Purpura Treatment Market by Treatment
10.3.6.6 Rest of Asia-Pacific Purpura Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Purpura Treatment Market by Type
10.3.6.6.2 Rest of Asia-Pacific Purpura Treatment Market by Cases
10.3.6.6.3 Rest of Asia-Pacific Purpura Treatment Market by Treatment
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Purpura Treatment Market Overview
10.4.2 Middle East and Africa Purpura Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Purpura Treatment Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Purpura Treatment Market Forecasts and Analysis - By Cases
10.4.5 Middle East and Africa Purpura Treatment Market Forecasts and Analysis - By Treatment
10.4.6 Middle East and Africa Purpura Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Purpura Treatment Market
10.4.6.1.1 South Africa Purpura Treatment Market by Type
10.4.6.1.2 South Africa Purpura Treatment Market by Cases
10.4.6.1.3 South Africa Purpura Treatment Market by Treatment
10.4.6.2 Saudi Arabia Purpura Treatment Market
10.4.6.2.1 Saudi Arabia Purpura Treatment Market by Type
10.4.6.2.2 Saudi Arabia Purpura Treatment Market by Cases
10.4.6.2.3 Saudi Arabia Purpura Treatment Market by Treatment
10.4.6.3 U.A.E Purpura Treatment Market
10.4.6.3.1 U.A.E Purpura Treatment Market by Type
10.4.6.3.2 U.A.E Purpura Treatment Market by Cases
10.4.6.3.3 U.A.E Purpura Treatment Market by Treatment
10.4.6.4 Rest of Middle East and Africa Purpura Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Purpura Treatment Market by Type
10.4.6.4.2 Rest of Middle East and Africa Purpura Treatment Market by Cases
10.4.6.4.3 Rest of Middle East and Africa Purpura Treatment Market by Treatment
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Purpura Treatment Market Overview
10.5.2 South and Central America Purpura Treatment Market Forecasts and Analysis
10.5.3 South and Central America Purpura Treatment Market Forecasts and Analysis - By Type
10.5.4 South and Central America Purpura Treatment Market Forecasts and Analysis - By Cases
10.5.5 South and Central America Purpura Treatment Market Forecasts and Analysis - By Treatment
10.5.6 South and Central America Purpura Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Purpura Treatment Market
10.5.6.1.1 Brazil Purpura Treatment Market by Type
10.5.6.1.2 Brazil Purpura Treatment Market by Cases
10.5.6.1.3 Brazil Purpura Treatment Market by Treatment
10.5.6.2 Argentina Purpura Treatment Market
10.5.6.2.1 Argentina Purpura Treatment Market by Type
10.5.6.2.2 Argentina Purpura Treatment Market by Cases
10.5.6.2.3 Argentina Purpura Treatment Market by Treatment
10.5.6.3 Rest of South and Central America Purpura Treatment Market
10.5.6.3.1 Rest of South and Central America Purpura Treatment Market by Type
10.5.6.3.2 Rest of South and Central America Purpura Treatment Market by Cases
10.5.6.3.3 Rest of South and Central America Purpura Treatment Market by Treatment
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PURPURA TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PURPURA TREATMENT MARKET, KEY COMPANY PROFILES
13.1. AMGEN INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BRISTOL-MYERS SQUIBB COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. F. HOFFMAN-LA ROCHE
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE PLC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GRIFOLS BIOLOGICALS INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. HOVIONE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVARTIS AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SANOFI
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. CELLTRION INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Amgen Inc
2. Bristol-Myers Squibb Company
3. F. Hoffman-La Roche
4. GlaxoSmithKline Plc.
5. Grifols Biologicals Inc
6. Hovione
7. Novartis AG
8. Pfizer Inc.
9. Sanofi
10. Celltrion Inc.
TIPRE00017823
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking